| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444138 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
Reference institutions for sarcomas may have improved their outcome in the last years. Although biases of retrospective analyses need to be discounted, it is possible that optimal exploitation of a series of subtle improvements in sarcoma treatment may make a difference in results achievable today.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Leonardo Duranti, Alessandro Gronchi, Silvia Stacchiotti, Marco Fiore, Paolo G. Casali, Paola Collini, Giuseppe Pelosi, Carlotta Galeone, Ugo Pastorino,